Gene · 3455
Papers3,850
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 3,850
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted mutations in IFNα2 improve its antiviral activity against various viruses. | mBio | 2023 | 37874130 | PubTator, text mining | PubMed |
| Transcriptome analysis reveals molecular mechanisms of lymphocystis formation caused by lymphocystis disease virus infection in flounder (Paralichthys olivaceus). | Front Immunol | 2023 | 37868974 | PubTator, text mining | PubMed |
| The role of the interferon/JAK-STAT axis in driving islet HLA-I hyperexpression in type 1 diabetes. | Front Endocrinol (Lausanne) | 2023 | 37867531 | PubTator, text mining | PubMed |
| Advances in understanding and treating diabetic kidney disease: focus on tubulointerstitial inflammation mechanisms. | Front Endocrinol (Lausanne) | 2023 | 37859992 | PubTator, text mining | PubMed |
| Potential network markers and signaling pathways for B cells of COVID-19 based on single-cell condition-specific networks. | BMC Genomics | 2023 | 37853311 | PubTator, text mining | PubMed |
| Gut-brain pathogenesis of post-acute COVID-19 neurocognitive symptoms. | Front Neurosci | 2023 | 37841680 | PubTator, text mining | PubMed |
| CRFB5a, a Subtype of Japanese Eel (Anguilla japonica) Type I IFN Receptor, Regulates Host Antiviral and Antimicrobial Functions through Activation of IRF3/IRF7 and LEAP2. | Animals (Basel) | 2023 | 37835763 | PubTator, text mining | PubMed |
| Neuropathic pain; what we know and what we should do about it. | Front Pain Res (Lausanne) | 2023 | 37810432 | PubTator, text mining | PubMed |
| Occurrence of SARS-CoV-2 viremia is associated with genetic variants of genes related to COVID-19 pathogenesis. | Front Med (Lausanne) | 2023 | 37809329 | PubTator, text mining | PubMed |
| Case Report: Response of cutaneous lupus lesions in SLE to interferon receptor blockade parallels reduction of interferon score in blood. | Front Immunol | 2023 | 37809086 | PubTator, text mining | PubMed |
| Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq. | Nat Commun | 2023 | 37803001 | PubTator, text mining | PubMed |
| Identification of human genetic variants modulating the course of COVID-19 infection with importance in other viral infections. | Front Genet | 2023 | 37795240 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens and their applications in infectious disease. | Front Genome Ed | 2023 | 37794981 | PubTator, text mining | PubMed |
| Effector memory T cells induce innate inflammation by triggering DNA damage and a non-canonical STING pathway in dendritic cells. | Cell Rep | 2023 | 37794597 | PubTator, text mining | PubMed |
| Characterization of 3D organotypic epithelial tissues reveals tonsil-specific differences in tonic interferon signaling. | PLoS One | 2023 | 37792852 | PubTator, text mining | PubMed |
| Endothelial type I interferon response and brain diseases: identifying STING as a therapeutic target. | Front Cell Dev Biol | 2023 | 37791071 | PubTator, text mining | PubMed |
| Potent antitumor efficacy of human dental pulp stem cells armed with YSCH-01 oncolytic adenovirus. | J Transl Med | 2023 | 37789452 | PubTator, text mining | PubMed |
| Peptide derived from SLAMF1 prevents TLR4-mediated inflammation in vitro and in vivo. | Life Sci Alliance | 2023 | 37788908 | PubTator, text mining | PubMed |
| Identification of Tumor Antigens and Immune Subtypes of High-grade Serous Ovarian Cancer for mRNA Vaccine Development. | J Cancer | 2023 | 37779866 | PubTator, text mining | PubMed |
| Diverse roles of lung macrophages in the immune response to influenza A virus. | Front Microbiol | 2023 | 37779697 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3455/papers?page=14